Semaglutide for bone health in type 2 diabetes
Part of Bones, joints & muscles, Hormones & metabolism, Injuries & trauma clinical trials.
This study tests a once-weekly medicine called semaglutide to see if it helps protect bones in people with type 2 diabetes who also have low bone density or have had a recent fracture. If you join, you'll receive semaglutide and your bone health will be monitored.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 75 years old
- You have type 2 diabetes (diagnosed by a doctor)
- Your last HbA1c test (average blood sugar over 3 months) was between 6.5% and 9%
- You have low bone density (T-score below -1) or you have had a fracture in your hip, spine, wrist, or upper arm within the last 3 years
- You have not used any diabetes medication (except metformin) in the last 8 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a diabetes medication called a GLP-1 receptor agonist can help improve bone and muscle health in older women with type 2 diabetes who are at risk for osteoporosis. It aims to see if the drug can strengthen bones and prevent falls.
This Phase 2 study tests semaglutide (a diabetes and weight-related medicine) to see if it can slow or improve diabetic kidney disease in people with type 1 diabetes. You may be able to join if you have type 1 diabetes for at least 5 years and ongoing signs of kidney damage measured in urine tests.
This study tests a new medication called semaglutide (similar to Ozempic) in people with type 2 diabetes who are already taking metformin. It aims to see if this medication improves blood sugar control and may also help with weight loss.
This study tests whether semaglutide, a medicine that helps control blood sugar and reduce weight, can benefit adults with type 1 diabetes who are overweight. If you qualify, you may receive the drug or a placebo, and the study team will monitor your health closely.
This study tests whether the diabetes medication semaglutide can reduce inflammation and improve blood vessel health in people with type 2 diabetes who have no significant heart artery blockages. If you have diabetes and are at moderate to high heart risk but haven't had heart problems, this could help understand the medicine's extra benefits beyond blood sugar control.
This trial studies whether semaglutide can improve heart and blood-vessel outcomes in people with type 1 diabetes who use an insulin pump or automated insulin delivery. It may help reduce cardiovascular risks, but you must meet several health and medication-safety requirements.
Hear when a new Osteoporosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.